Training program for cancer immunotherapy researchers
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
['FUNDING_OTHER'] · YALE UNIVERSITY · NIH-10933399
This program at Yale University is helping new researchers learn about cancer treatments that use the immune system, so they can find better ways to help patients with cancer feel better and live longer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10933399 on ClinicalTrials.gov |
What this research studies
This program at Yale University focuses on training junior investigators in the field of cancer immunology and immunotherapy. It aims to enhance understanding of immune modulation therapies that can improve patient outcomes in cancer treatment. Participants will engage in patient-oriented research, exploring drug combinations, immune suppression mechanisms, and trial designs specific to immune therapies. The program supports the development of new researchers who will contribute to advancements in cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are junior faculty members or scholars in the medical field interested in cancer immunology and immunotherapy.
Not a fit: Patients who are not involved in academic or clinical research training may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments through better understanding and application of immunotherapy.
How similar studies have performed: Previous training programs in similar fields have shown success in developing independent researchers and advancing cancer treatment methodologies.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KLUGER, HARRIET M. — YALE UNIVERSITY
- Study coordinator: KLUGER, HARRIET M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center Director